Shares of Copart (CPRT.US) gain 9% today after strong earnings report with revenues up almost 12.5% YoY. Morningstar' analysts named Copart one of the strongest moats in the auto industry. The company receives the majority of its vehicle volume through contracts with large auto insurance firms and sells them on consignment for high margins, often to dismantles. Wall Street almost ignored some pressure on company margins.
- The vehicle auction company posted adjusted EPS of $0.37, in line with the consensus and aboce $0.34 in Q3 2023; up 8.8% YoY. Revenue came in at $1.15 billion, above $1.09 billion estimated on Wall Street. It is a 12.4% YoY increase from $1.02 billion in the Q3 2023.
- Service revenues grew 14.8% YoY to $986.3 million, but vehicle sales dipped only slightly by 0.2% to $160.5 million. However, the market expects that auto sales will rise in Q4 and through 2025 with lower Fed rates stimulating vehicles demand.
- Net income rose 8.9% YoY to $362.1 million, with gross profit at $512.1 million (10.4% YoY). The company commented positively about its global expansion and technology investments; connecting 'more buyers and sellers in our marketplace'.
Source: xStation5
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appThe material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.